Annual Total Long Term Liabilities
$5.40 M
-$2.14 M-28.37%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual total long term liabilities is $5.40 million, with the most recent change of -$2.14 million (-28.37%) on December 31, 2023.
- During the last 3 years, APVO annual total long term liabilities has fallen by -$17.02 million (-75.92%).
- APVO annual total long term liabilities is now -75.92% below its all-time high of $22.41 million, reached on December 31, 2020.
Performance
APVO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$4.84 M
-$195.00 K-3.87%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly total long term liabilities is $4.84 million, with the most recent change of -$195.00 thousand (-3.87%) on September 30, 2024.
- Over the past year, APVO quarterly long term liabilities has dropped by -$553.00 thousand (-10.25%).
- APVO quarterly long term liabilities is now -83.24% below its all-time high of $28.91 million, reached on March 31, 2021.
Performance
APVO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
APVO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.4% | -10.3% |
| 3 y3 years | -75.9% | -10.3% |
| 5 y5 years | -72.3% | +45.6% |
APVO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.8% | at low | -82.2% | at low |
| 5 y | 5-year | -75.9% | +62.2% | -83.2% | +69.5% |
| alltime | all time | -75.9% | +62.2% | -83.2% | +69.5% |
Aptevo Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.84 M(-3.9%) |
| Jun 2024 | - | $5.04 M(-3.6%) |
| Mar 2024 | - | $5.23 M(-3.1%) |
| Dec 2023 | $5.40 M(-28.4%) | $5.40 M(-3.2%) |
| Sep 2023 | - | $5.58 M(-3.0%) |
| Jun 2023 | - | $5.75 M(-2.8%) |
| Mar 2023 | - | $5.92 M(-21.5%) |
| Dec 2022 | $7.54 M(-63.5%) | $7.54 M(-7.5%) |
| Sep 2022 | - | $8.15 M(-6.9%) |
| Jun 2022 | - | $8.75 M(-67.8%) |
| Mar 2022 | - | $27.21 M(+31.9%) |
| Dec 2021 | $20.63 M(-8.0%) | $20.63 M(-15.2%) |
| Sep 2021 | - | $24.33 M(-9.0%) |
| Jun 2021 | - | $26.73 M(-7.5%) |
| Mar 2021 | - | $28.91 M(+29.0%) |
| Dec 2020 | $22.41 M | $22.41 M(-19.4%) |
| Sep 2020 | - | $27.80 M(+873.1%) |
| Jun 2020 | - | $2.86 M(-7.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.10 M(-6.9%) |
| Dec 2019 | $3.33 M(-82.9%) | $3.33 M(-6.5%) |
| Sep 2019 | - | $3.56 M(-84.7%) |
| Jun 2019 | - | $23.33 M(-0.4%) |
| Mar 2019 | - | $23.42 M(+20.2%) |
| Dec 2018 | $19.48 M(+18.3%) | $19.48 M(-0.1%) |
| Sep 2018 | - | $19.49 M(+22.9%) |
| Jun 2018 | - | $15.87 M(+8.9%) |
| Mar 2018 | - | $14.57 M(-11.5%) |
| Dec 2017 | $16.46 M(-24.3%) | $16.46 M(-36.3%) |
| Sep 2017 | - | $25.84 M(+9.6%) |
| Jun 2017 | - | $23.59 M(+8.0%) |
| Mar 2017 | - | $21.85 M(+0.5%) |
| Dec 2016 | $21.75 M(+13.2%) | $21.75 M(+0.5%) |
| Sep 2016 | - | $21.64 M(+450.1%) |
| Jun 2016 | - | $3.93 M(-2.9%) |
| Mar 2016 | - | $4.05 M(-78.9%) |
| Dec 2015 | $19.21 M(+247.4%) | $19.21 M |
| Dec 2014 | $5.53 M | - |
FAQ
- What is Aptevo Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual total long term liabilities year-on-year change?
- What is Aptevo Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly long term liabilities year-on-year change?
What is Aptevo Therapeutics annual total long term liabilities?
The current annual total long term liabilities of APVO is $5.40 M
What is the all time high annual total long term liabilities for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual total long term liabilities is $22.41 M
What is Aptevo Therapeutics annual total long term liabilities year-on-year change?
Over the past year, APVO annual total long term liabilities has changed by -$2.14 M (-28.37%)
What is Aptevo Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of APVO is $4.84 M
What is the all time high quarterly long term liabilities for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly total long term liabilities is $28.91 M
What is Aptevo Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, APVO quarterly total long term liabilities has changed by -$553.00 K (-10.25%)